# InnoMed Capital

> InnoMed Capital is a VC fund backing Medical, Biotechnology and Manufacturing. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Jul 2023
- Lead investor: 33%
- Last updated: Aug 2026

InnoMed Capital is a VC fund focused on Medical and Biotechnology. InnoMed Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 50% |
| Biotechnology | 3 | 50% |
| Manufacturing | 2 | 33% |
| Chemical | 1 | 17% |
| Biopharma | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 50% |
| Seed | 1 | 17% |
| Angel | 1 | 17% |
| Series B | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lanboto | Lanboto is an animal health firm focused on the research and development, production, sales, and servicing of new pet medicines. | $14.2M | Series B | Jul 13, 2023 |  |
| Eaglenos | Eaglenos is an IVD company that specialises in medical POCT, home health care devices, and health management systems. It focuses on chemistry, materials, electronics, software, machinery, and biomedical engineering. It helps in the advancement of electrochemistry, microfluidics, signal acquisition, and automation technologies. | $21.2M | Series A | May 29, 2023 |  |
| Polarisic | PolarisIC develops depth perception and low-light imaging chip products. | $12.9M | Seed | Dec 14, 2022 |  |
| ChomiX Biotech | ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry. | $1.5M | Angel | Jul 15, 2021 |  |
| Novlead Biotech | Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations. |  | Series A | Jan 01, 2021 |  |
| InxMed | InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $19M | Series A | Sep 04, 2020 |  |

6 of 6 investments shown.

## Co-investors
- Eagle Alliance Capital — VC Fund, 2 deals together
- [Grand Yangtze Capital](https://shizune.co/investors/profile/grand-yangtze-capital) — VC Fund, 2 deals together
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [China Growth Capital](https://shizune.co/investors/profile/china-growth-capital) — VC Fund, 1 deal together
- [Dami Ventures](https://shizune.co/investors/profile/dami-ventures) — VC Fund, 1 deal together
- [Ennovation Ventures](https://shizune.co/investors/profile/ennovation-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does InnoMed Capital invest in?

InnoMed Capital invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did InnoMed Capital last invest?

The most recent investment recorded for InnoMed Capital closed in Jul 2023. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co